Efficacy of citicoline as neuroprotector in post cardiac arrest in PICU; A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR201907742119058

Enrollment

Registered

2019-07-22

Start date

2019-05-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases Paediatrics

Interventions

Citicoline

placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children post cardiac arrest (regardless the cause) who are successfully resuscitated with return of spontaneous circulation and who are unconscious with Glasgow coma scale (GCS) below 7

Exclusion criteria

Exclusion criteria: Post cardiac arrest patients who received any neuroprotective maneuver or drugs like hypothermia

Design outcomes

Primary

Measure	Time frame
glascow coma score	—

Secondary

Measure	Time frame
frequency, type and duration of seizures, duration of PICU stay, pupillary light and corneal reflexes, side effects, mortality, and modified Rankin scale for children	—

Countries

Egypt

Contacts

Public ContactAmr Zoair

Professor of pediatrics and dean of Faculty of medicine Tanta University Egypt

azoair@hotmail.com00201001108683

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026